secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2026-08-13T12:30:26+00:00
Accession:  0001213900-26-088726
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SS Innovations Q2 revenue up 39% to $13.9M; net loss widens to $2.7M
--------------------------------------------------------------------

- Revenue $13.9M, +39.4% YoY; gross margin 50.9% vs 59.1% prior year.
- Net loss $2.7M ($0.01/share) vs $0.3M loss in Q2 2025.
- SSi Mantra installations 30 in Q2 (+30.4%); cumulative base 224 systems, 12,272 surgeries.
- H1 revenue $25.0M (+65.6%); net loss $6.2M vs $5.9M.
- FDA 510(k) decision expected by end Q1 2027; EU CE mark targeted by end 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/0001213900-26-088726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/ea0301887-8k_ssinnova.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-088726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer